ISY9-3 Proteomic and T cell biomarkers identify sensitivity and resistance to immunotherapy in cancer patients
Weber J, Woods D, Laino A, Kluger H, Halaban R, Sznol M, Roder H, Roder J, Blackmon K, Sullivan R. ISY9-3 Proteomic and T cell biomarkers identify sensitivity and resistance to immunotherapy in cancer patients. Annals Of Oncology 2017, 28: ix21. DOI: 10.1093/annonc/mdx553.001.Peer-Reviewed Original Research